Of note, none of the tested biomarkers of metabolism and inflammation (adiponectin, leptin, resistin, C-reactive protein, TNF-α, IL-6, IL-8 and IFN-γ) was significantly associated with liver fat content or NAFLD in our regression analyses. Here, RETN is linked to metabolic dysfunction-associated steatotic liver disease.